×
About 77,238 results

ALLMedicine™ Cirrhosis Center

Research & Reviews  36,257 results

Impaired antibacterial response of liver sinusoidal Vγ9+Vδ2+ T cells in patients with c...
https://doi.org/10.1136/gutjnl-2020-322182
Gut Rha MS, Han JW et. al.

Jan 21st, 2021 - The liver acts as a frontline barrier against diverse gut-derived pathogens, and the sinusoid is the primary site of liver immune surveillance. However, little is known about liver sinusoidal immune cells in the context of chronic liver disease (C...

Non-invasive Assessment of Liver Fat in ob/ob Mice Using Ultrasound-Induced Thermal Str...
https://doi.org/10.1016/j.ultrasmedbio.2020.12.014
Ultrasound in Medicine & Biology; Khalid WB, Farhat N et. al.

Jan 20th, 2021 - Non-alcoholic fatty liver disease is the accumulation of triglycerides in liver. In its malignant form, it can proceed to steatohepatitis, fibrosis, cirrhosis, cancer and ultimately liver impairment, leading to liver transplantation. In a previous...

Sleep disruption in nonalcoholic fatty liver disease: What is the role of lifestyle and...
https://doi.org/10.1097/MEG.0000000000002049
European Journal of Gastroenterology & Hepatology; Akram ST, Ewy MW et. al.

Jan 20th, 2021 - Patients with nonalcoholic fatty liver disease (NAFLD) have sleep disruption. The aim of this study is to understand how underlying factors such as diet, degree of liver disease and morningness-eveningness tendencies contribute to this sleep disru...

Consensus for management of portal vein thrombosis in liver cirrhosis (2020, Shanghai).
https://doi.org/10.1111/1751-2980.12970
Journal of Digestive Diseases; Xie WF, Wang JY et. al.

Jan 20th, 2021 - Portal vein thrombosis is a common and severe complication of liver cirrhosis. So far, there has been no consensus or practice guidelines on the management of portal vein thrombosis in liver cirrhosis. In this expert consensus we systematically re...

Review article: safety of new biologic agents for inflammatory bowel disease in the liver.
https://doi.org/10.1097/MEG.0000000000002076
European Journal of Gastroenterology & Hepatology; Magrì S, Chessa L et. al.

Jan 20th, 2021 - New biologic agents (vedolizumab, ustekinumab and tofacitinib) represent an effective treatment for inflammatory bowel diseases and have been recently approved. However, with a rapidly evolving complement of advanced targeted therapies, new concer...

see more →

Guidelines  109 results

AGA Clinical Practice Update on Bariatric Surgery in Cirrhosis: Expert Review.
https://doi.org/10.1016/j.cgh.2020.10.034
Clinical Gastroenterology and Hepatology : the Official C... Patton H, Heimbach J et. al.

Jan 4th, 2021 - AGA Clinical Practice Update on Bariatric Surgery in Cirrhosis: Expert Review.|2021|Patton H,Heimbach J,McCullough A,|

AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achie...
https://doi.org/10.1053/j.gastro.2020.11.051
Gastroenterology Younossi ZM, Corey KE et. al.

Dec 11th, 2020 - Nonalcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease, with global public health impact affecting more than 25% of the global population. NAFLD is associated with significant morbidity and mortality from cirrhosis, h...

AGA Clinical Practice Update on Palliative Care Management in Cirrhosis: Expert Review.
https://doi.org/10.1016/j.cgh.2020.11.027
Clinical Gastroenterology and Hepatology : the Official C... Tandon P, Walling A et. al.

Nov 22nd, 2020 - Care with palliative care principles (aka Palliative Care, PC) is an approach to care that focuses on improving the quality of life of patients and their caregivers who are facing life-limiting illness. It encompasses the assessment and management...

ACR Appropriateness Criteria® Radiologic Management of Gastric Varices.
https://doi.org/10.1016/j.jacr.2020.01.017
Journal of the American College of Radiology : JACR; , Kim CY et. al.

May 5th, 2020 - Hemorrhage, resulting from gastric varies, can be challenging to treat, given the various precipitating etiologies. A wide variety of treatment options exist for managing the diverse range of the underlying disease processes. While cirrhosis is th...

ACR Appropriateness Criteria® Chronic Liver Disease.
https://doi.org/10.1016/j.jacr.2020.01.023
Journal of the American College of Radiology : JACR; , Bashir MR et. al.

May 5th, 2020 - The liver fibrosis stage is the most important clinical determinate of morbidity and mortality in patients with chronic liver diseases. With newer therapies, liver fibrosis can be stabilized and possibly reversed, thus accurate diagnosis and stagi...

see more →

Drugs  849 results see all →

Clinicaltrials.gov  38,285 results

Impaired antibacterial response of liver sinusoidal Vγ9+Vδ2+ T cells in patients with c...
https://doi.org/10.1136/gutjnl-2020-322182
Gut Rha MS, Han JW et. al.

Jan 21st, 2021 - The liver acts as a frontline barrier against diverse gut-derived pathogens, and the sinusoid is the primary site of liver immune surveillance. However, little is known about liver sinusoidal immune cells in the context of chronic liver disease (C...

Non-invasive Assessment of Liver Fat in ob/ob Mice Using Ultrasound-Induced Thermal Str...
https://doi.org/10.1016/j.ultrasmedbio.2020.12.014
Ultrasound in Medicine & Biology; Khalid WB, Farhat N et. al.

Jan 20th, 2021 - Non-alcoholic fatty liver disease is the accumulation of triglycerides in liver. In its malignant form, it can proceed to steatohepatitis, fibrosis, cirrhosis, cancer and ultimately liver impairment, leading to liver transplantation. In a previous...

Sleep disruption in nonalcoholic fatty liver disease: What is the role of lifestyle and...
https://doi.org/10.1097/MEG.0000000000002049
European Journal of Gastroenterology & Hepatology; Akram ST, Ewy MW et. al.

Jan 20th, 2021 - Patients with nonalcoholic fatty liver disease (NAFLD) have sleep disruption. The aim of this study is to understand how underlying factors such as diet, degree of liver disease and morningness-eveningness tendencies contribute to this sleep disru...

Consensus for management of portal vein thrombosis in liver cirrhosis (2020, Shanghai).
https://doi.org/10.1111/1751-2980.12970
Journal of Digestive Diseases; Xie WF, Wang JY et. al.

Jan 20th, 2021 - Portal vein thrombosis is a common and severe complication of liver cirrhosis. So far, there has been no consensus or practice guidelines on the management of portal vein thrombosis in liver cirrhosis. In this expert consensus we systematically re...

Review article: safety of new biologic agents for inflammatory bowel disease in the liver.
https://doi.org/10.1097/MEG.0000000000002076
European Journal of Gastroenterology & Hepatology; Magrì S, Chessa L et. al.

Jan 20th, 2021 - New biologic agents (vedolizumab, ustekinumab and tofacitinib) represent an effective treatment for inflammatory bowel diseases and have been recently approved. However, with a rapidly evolving complement of advanced targeted therapies, new concer...

see more →

News  1,647 results

Polygenic Score Pinpoints People Most at Risk of Cirrhosis
https://www.medscape.com/viewarticle/943026

Dec 21st, 2020 - NEW YORK (Reuters Health) - A polygenic score that includes seven newly-identified genetic variants pinpointed individuals at "substantially increased risk" of cirrhosis if they drink to excess or are obese, researchers say. "Although studies on t...

Even Mild NAFLD Associated With Higher Mortality
https://www.medscape.com/viewarticle/941350

Nov 22nd, 2020 - NEW YORK (Reuters Health) - All stages of nonalcoholic fatty liver disease (NAFLD) are associated with significantly increased overall mortality, and this risk increases progressively with worsening disease, Swedish researchers have found. Deaths ...

Liver Cancer Rates Are Rising; So Is Optimism Around Its Treatment
https://www.medscape.com/viewarticle/941160

Nov 19th, 2020 - In celebration of Medscape's 25th birthday, we are highlighting key breakthroughs that have defined the last quarter century of medicine, as chosen by experts in their respective fields. Over the past 25 years, cirrhosis and its related complicati...

Aspirin and Statins in Chronic Hepatitis B: It's Complicated
https://www.staging.medscape.com/viewarticle/941289

Nov 18th, 2020 - For patients with chronic hepatitis B, the protective effects of aspirin against hepatocellular carcinoma (HCC) can vary with cirrhosis status and statin treatment, a pair of new studies finds. One study showed that although aspirin is linked to a...

Aspirin and Statins in Chronic Hepatitis B: It's Complicated
https://www.medscape.com/viewarticle/941289

Nov 18th, 2020 - For patients with chronic hepatitis B, the protective effects of aspirin against hepatocellular carcinoma (HCC) can vary with cirrhosis status and statin treatment, a pair of new studies finds. One study showed that although aspirin is linked to a...

see more →

Patient Education  91 results see all →